IL314788A - Modified release valproic acid softgel capsule - Google Patents

Modified release valproic acid softgel capsule

Info

Publication number
IL314788A
IL314788A IL314788A IL31478824A IL314788A IL 314788 A IL314788 A IL 314788A IL 314788 A IL314788 A IL 314788A IL 31478824 A IL31478824 A IL 31478824A IL 314788 A IL314788 A IL 314788A
Authority
IL
Israel
Prior art keywords
valproic acid
soft
concentration capsule
capsule
soft concentration
Prior art date
Application number
IL314788A
Other languages
English (en)
Hebrew (he)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Karunakar Sukuru
Qi Fang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P, Karunakar Sukuru, Qi Fang filed Critical Scherer Technologies Llc R P
Publication of IL314788A publication Critical patent/IL314788A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL314788A 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule IL314788A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263311559P 2022-02-18 2022-02-18
PCT/US2023/013277 WO2023158777A1 (en) 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule

Publications (1)

Publication Number Publication Date
IL314788A true IL314788A (en) 2024-10-01

Family

ID=87579078

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314788A IL314788A (en) 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule

Country Status (12)

Country Link
US (1) US20250177312A1 (cg-RX-API-DMAC10.html)
EP (1) EP4479033A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025506678A (cg-RX-API-DMAC10.html)
KR (1) KR20240145031A (cg-RX-API-DMAC10.html)
CN (1) CN118647373A (cg-RX-API-DMAC10.html)
AR (1) AR128560A1 (cg-RX-API-DMAC10.html)
AU (1) AU2023221972A1 (cg-RX-API-DMAC10.html)
CA (1) CA3244352A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024012216A2 (cg-RX-API-DMAC10.html)
IL (1) IL314788A (cg-RX-API-DMAC10.html)
MX (1) MX2024010123A (cg-RX-API-DMAC10.html)
WO (1) WO2023158777A1 (cg-RX-API-DMAC10.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437006B1 (en) * 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
CA2853965A1 (en) * 2011-11-03 2013-05-10 Gtx, Inc. Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
US20170312226A1 (en) * 2016-04-28 2017-11-02 Ascent Pharmaceuticals, Inc. Pharmaceutical dosage forms
CN114072138A (zh) * 2019-06-03 2022-02-18 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment
CA3185807A1 (en) * 2020-06-02 2021-12-02 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Also Published As

Publication number Publication date
AR128560A1 (es) 2024-05-22
CA3244352A1 (en) 2023-08-24
KR20240145031A (ko) 2024-10-04
WO2023158777A1 (en) 2023-08-24
MX2024010123A (es) 2024-08-27
CO2024012216A2 (es) 2024-09-30
US20250177312A1 (en) 2025-06-05
CN118647373A (zh) 2024-09-13
EP4479033A1 (en) 2024-12-25
AU2023221972A1 (en) 2024-09-19
EP4479033A4 (en) 2026-03-04
JP2025506678A (ja) 2025-03-13

Similar Documents

Publication Publication Date Title
EP4389891A4 (en) MODIFIED HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID
CL2017003218A1 (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
SG10201811186XA (en) Purification of proteins
EP4161580A4 (en) BIOCONJUGATES OF CANNABINOID HYALURONIC ACID
EA201990415A1 (ru) Плавучий модуль для модульных платформ солнечных панелей
MX363408B (es) Composicion que contiene peroxido y acido peracetico y proceso para matar esporas.
EP4588459A4 (en) VASCULAR ENDOPROSTHESIS
EP3830103C0 (en) FLUORINATED BILE ACID DERIVATIVES
EP3697763A4 (en) D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF
EP4479095C0 (en) STABILIZED STEALTH LIPO-POLYAMINE ACIDS
CO2020012963A2 (es) Composición farmacéutica y método de fabricación
IL305851A (en) Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid
EP4032411A4 (en) COMPOSITION CONTAINING ACIDIC ACID BACTERIA
UY33455A (es) Tableta con núcleo recubierto de liberación controlada
EP4368708A4 (en) NUCLEIC ACID LIGASE
EP4087904A4 (en) Derivatized polyamino acids
IL280749A (en) Microorganisms with improved 1,3-propanediol and butyric acid production
IL314508A (en) Theragnostic folate conjugates
IL272443A (en) Glycyrrhetinic acid derivatives for treating hyperkalemia
EP4527285A4 (en) ENDOSCOPE
EP4464233A4 (en) Endoscope
IT202200015738A1 (it) Succhietto
LT3980003T (lt) [((1r,2s,5r)-2-izopropil-5-metil-cikloheksankarbonil)-amino]-acto rūgšties izopropilo esteris, skirtas lėtinio kosulio gydymui
ES2528394B1 (es) Procedimiento de hidrólisis de biomasa lignocelulósica
IL285235A (en) Glycyrrhetinic acid derivatives for use in treating hyperkalemia